Emily Barron-Casella
Overview
Explore the profile of Emily Barron-Casella including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
245
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lance E, Faulcon L, Fu Z, Yang J, Whyte-Stewart D, Strouse J, et al.
Proteomics Clin Appl
. 2021 Apr;
15(5):e2100003.
PMID: 33915030
Purpose: Sickle cell disease (SCD) is an inherited hemoglobinopathy that causes stroke and silent cerebral infarct (SCI). Our aim was to identify markers of brain injury in SCD. Experimental Design:...
2.
Lance E, Barron-Casella E, Everett A, Casella J
Pediatr Blood Cancer
. 2019 Nov;
67(2):e28076.
PMID: 31736231
Background: Children with sickle cell disease (SCD) have an increased risk of neurological complications, particularly stroke and silent cerebral infarction (SCI). Brain-derived neurotrophic factor (BDNF) is a nerve growth factor...
3.
Chaturvedi S, Bhatnagar P, Bean C, Steinberg M, Milton J, Casella J, et al.
Blood
. 2017 Jun;
130(5):686-688.
PMID: 28584135
No abstract available.
4.
Lance E, Casella J, Everett A, Barron-Casella E
Proteomics Clin Appl
. 2014 Oct;
8(11-12):813-27.
PMID: 25290359
Biomarker analysis and proteomic discovery in pediatric sickle cell disease has the potential to lead to important discoveries and improve care. The aim of this review article is to describe...
5.
Bhatnagar P, Barron-Casella E, Bean C, Milton J, Baldwin C, Steinberg M, et al.
PLoS One
. 2013 Sep;
8(9):e74193.
PMID: 24058526
In pediatric sickle cell disease (SCD) patients, it has been reported that higher systolic blood pressure (SBP) is associated with increased risk of a silent cerebral infarction (SCI). SCI is...
6.
Faulcon L, Fu Z, Dulloor P, Barron-Casella E, Savage W, Jennings J, et al.
Br J Haematol
. 2013 May;
162(3):421-4.
PMID: 23672305
No abstract available.
7.
Thangarajh M, Yang G, Fuchs D, Ponisio M, McKinstry R, Jaju A, et al.
Br J Haematol
. 2012 Sep;
159(3):352-9.
PMID: 22958163
Silent cerebral infarct (SCI) is the most commonly recognized cause of neurological injury in sickle cell anaemia (SCA). We tested the hypothesis that magnetic resonance angiography (MRA)-defined vasculopathy is associated...
8.
Bae H, Baldwin C, Sebastiani P, Telen M, Ashley-Koch A, Garrett M, et al.
Blood
. 2012 Sep;
120(9):1961-2.
PMID: 22936743
No abstract available.
9.
Milton J, Sebastiani P, Solovieff N, Hartley S, Bhatnagar P, Arking D, et al.
PLoS One
. 2012 May;
7(4):e34741.
PMID: 22558097
Serum bilirubin levels have been associated with polymorphisms in the UGT1A1 promoter in normal populations and in patients with hemolytic anemias, including sickle cell anemia. When hemolysis occurs circulating heme...
10.
Savage W, Barron-Casella E, Fu Z, Dulloor P, Williams L, Crain B, et al.
Am J Hematol
. 2011 Apr;
86(5):427-9.
PMID: 21523806
To determine if glial fibrillary acidic protein (GFAP) is associated with brain injury in children with sickle cell disease (SCD), we measured plasma GFAP among cross-sectional groups of unselected children...